Vascular Health and Risk Management Dovepress Exercise Electrocardiographic Responses and Serum Cystatin C Levels among Metabolic Syndrome Patients without Overt Diabetes Mellitus
暂无分享,去创建一个
H. Paşaoğlu | B. Çelik | B. Boyacı | A. Tanındı | A. Tuncel | Hilal Olgun
[1] K. Indulekha,et al. Association of cystatin-C with metabolic syndrome in normal glucose-tolerant subjects (CURES-97). , 2010, Diabetes technology & therapeutics.
[2] Joseph Lau,et al. The Vulnerable Atherosclerotic Plaque: Scope of the Literature , 2010, Annals of Internal Medicine.
[3] H. Völzke,et al. Mild renal dysfunction as a non-traditional cardiovascular risk factor?-Association of cystatin C-based glomerular filtration rate with flow-mediated vasodilation. , 2010, Atherosclerosis.
[4] S. Blair,et al. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome. , 2010, Mayo Clinic proceedings.
[5] H. Kwon,et al. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. , 2010, Metabolism: clinical and experimental.
[6] M. Batista,et al. Is Cystatin C a Useful Marker in the Detection of Diabetic Kidney Disease? , 2009, Nephron Clinical Practice.
[7] M. Shlipak,et al. Association of Cystatin C with Ischemia in Patients with Coronary Heart Disease , 2009, Clinical cardiology.
[8] F. Giallauria,et al. Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study , 2009, Journal of ovarian research.
[9] M. Shlipak,et al. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA) , 2008, BMC nephrology.
[10] P. Giral,et al. Is serum cystatin-C a reliable marker for metabolic syndrome? , 2008, The American journal of medicine.
[11] P. Hedberg,et al. Heart rate recovery is more strongly associated with the metabolic syndrome, waist circumference, and insulin sensitivity in women than in men among the elderly in the general population. , 2007, American heart journal.
[12] M. Trevisan,et al. Elevated Cystatin C Concentration and Progression to Pre-Diabetes , 2007, Diabetes Care.
[13] Yves Papelier,et al. Noninvasive assessment of cardiac parasympathetic function: postexercise heart rate recovery or heart rate variability? , 2007, American journal of physiology. Heart and circulatory physiology.
[14] B. Zinman,et al. Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth , 2007, Pediatric Nephrology.
[15] D. McManus,et al. Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] M. Shlipak,et al. Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study , 2006, Circulation.
[17] D. Jacobs,et al. The temporal relationship between heart rate recovery immediately after exercise and the metabolic syndrome: the CARDIA study. , 2006, European heart journal.
[18] H. Leu,et al. Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test , 2005, Heart.
[19] D. Siscovick,et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.
[20] G. Curhan. Cystatin C: a marker of renal function or something more? , 2005, Clinical chemistry.
[21] H. Brenner,et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. , 2005, Clinical chemistry.
[22] T. Takano,et al. Impaired baroreflex as a cause of chronotropic incompetence during exercise via autonomic mechanism in patients with heart disease. , 2004, International journal of cardiology.
[23] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[24] G. Vanzetto,et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. , 2004, Diabetes & metabolism.
[25] Eugene H Blackstone,et al. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. , 2003, Journal of the American College of Cardiology.
[26] M. Lauer,et al. Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. , 2003, Diabetes care.
[27] Christopher J O'Donnell,et al. Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (The Framingham Heart Study). , 2002, The American journal of cardiology.
[28] M. Lauer. Exercise testing for assessment of autonomic function. , 2002, American heart journal.
[29] B. Hoogwerf,et al. Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. , 2002, Diabetes.
[30] M. Lauer,et al. Association of smoking with abnormal exercise heart rate responses and long-term prognosis in a healthy, population-based cohort. , 2000, The American journal of medicine.
[31] M. Lauer,et al. Heart-rate recovery immediately after exercise as a predictor of mortality. , 1999, The New England journal of medicine.
[32] P. Fernlund,et al. Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[33] D. Levy,et al. Association of cigarette smoking with chronotropic incompetence and prognosis in the Framingham Heart Study. , 1997, Circulation.
[34] P Kligfield,et al. Chronotropic response to exercise. Improved performance of ST-segment depression criteria after adjustment for heart rate reserve. , 1996, Circulation.
[35] M. Ellestad,et al. Chronotropic incompetence. The implications of heart rate response to exercise (compensatory parasympathetic hyperactivity?) , 1996, Circulation.
[36] P M Okin,et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. , 1996, Circulation.
[37] F. Harrell,et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. , 1991, The New England journal of medicine.
[38] H. R. Peterson,et al. Body fat and the activity of the autonomic nervous system. , 1988, The New England journal of medicine.
[39] R. Krauss,et al. Diagnosis and management of the metabolic syndrome , 2005 .
[40] J. Keaney,et al. Endothelial function: a barometer for cardiovascular risk? , 2002, Circulation.
[41] E. Antman,et al. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing) , 2002 .